Literature DB >> 18773049

Local surgical resection of hilar cholangiocarcinoma: is there still a place?

L Capussotti1, L Vigano, A Ferrero, A Muratore.   

Abstract

In recent decades, surgical treatment of hilar cholangiocarcinoma has moved toward liver surgery in association with biliary resection in order to increase radicality and to achieve better survival. Results of local resection compared with hepatectomy associated with bile duct resection and its actual indications have to be clarified. A systematic review of relevant studies published before December 2007 was performed. Original published studies comparing the results of isolated local excision with those of hepatectomy associated with bile duct resection were identified and the reported results were synthesized. The pathologic data suggest that isolated bile duct resection cannot be adequate: required wide surgical margins; neoplastic extension along perineural sheaths; Segment 1 neoplastic invasion. Considering postoperative outcomes, in the 1990s, local resection had significantly lower mortality rates than liver resection. In recent years, the short-term results of liver surgery have improved significantly, while mortality rates have decreased. The R0 resection rate is significantly higher after associated liver resection. Comparison of survival results between local resection and associated liver surgery is difficult because, in the majority of series, the treatment was planned according to tumor extension. Better long-term outcomes have been reported after liver resection than after isolated bile duct resection, even for Bismuth-Corlette type I-II cholangiocarcinoma. Long-term survivors after local resection have been reported in a few selected patients with Bismuth-Corlette type I Tis-T1 or papillary neoplasm.

Entities:  

Year:  2008        PMID: 18773049      PMCID: PMC2504370          DOI: 10.1080/13651820801992534

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  39 in total

1.  Management of proximal cholangiocarcinomas by surgical resection and radiotherapy.

Authors:  J L Cameron; H A Pitt; M J Zinner; S L Kaufman; J Coleman
Journal:  Am J Surg       Date:  1990-01       Impact factor: 2.565

2.  One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality.

Authors:  Tsuyoshi Sano; Kazuaki Shimada; Yoshihiro Sakamoto; Junji Yamamoto; Susumu Yamasaki; Tomoo Kosuge
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

3.  Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.

Authors:  Helmut Witzigmann; Frieder Berr; Ulrike Ringel; Karel Caca; Dirk Uhlmann; Konrad Schoppmeyer; Andrea Tannapfel; Christian Wittekind; Joachim Mossner; Johann Hauss; Marcus Wiedmann
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

4.  Proximal bile duct cancer: high resectability rate and 5-year survival.

Authors:  B Launois; J Terblanche; M Lakehal; J M Catheline; E Bardaxoglou; S Landen; J P Campion; F Sutherland; B Meunier
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

5.  Clinicopathological review of 61 patients with early bile duct cancer.

Authors:  J M Cha; M H Kim; S K Lee; D W Seo; S S Lee; J H Lee; S G Lee; S J Jang
Journal:  Clin Oncol (R Coll Radiol)       Date:  2006-11       Impact factor: 4.126

6.  Actual long-term outcome of extrahepatic bile duct cancer after surgical resection.

Authors:  Jin-Young Jang; Sun-Whe Kim; Do Joong Park; Young Joon Ahn; Yoo-Seok Yoon; Min Gew Choi; Kyung-Suk Suh; Kuhn Uk Lee; Yong-Hyun Park
Journal:  Ann Surg       Date:  2005-01       Impact factor: 12.969

7.  Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor).

Authors:  Sander Dinant; Michael F Gerhards; E A J Rauws; Olivier R C Busch; Dirk J Gouma; Thomas M van Gulik
Journal:  Ann Surg Oncol       Date:  2006-04-14       Impact factor: 5.344

8.  Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

Authors:  Michelle L DeOliveira; Steven C Cunningham; John L Cameron; Farin Kamangar; Jordan M Winter; Keith D Lillemoe; Michael A Choti; Charles J Yeo; Richard D Schulick
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

9.  Role of nodal involvement and the periductal soft-tissue margin in middle and distal bile duct cancer.

Authors:  M Kayahara; T Nagakawa; T Ohta; H Kitagawa; H Tajima; K Miwa
Journal:  Ann Surg       Date:  1999-01       Impact factor: 12.969

10.  Surgical approach to bismuth Type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases.

Authors:  Takashi Ikeyama; Masato Nagino; Koji Oda; Tomoki Ebata; Hideki Nishio; Yuji Nimura
Journal:  Ann Surg       Date:  2007-12       Impact factor: 12.969

View more
  5 in total

Review 1.  Perihilar cholangiocarcinoma: Current therapy.

Authors:  Wei Zhang; Lu-Nan Yan
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

Review 2.  Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making.

Authors:  Irinel Popescu; Traian Dumitrascu
Journal:  Langenbecks Arch Surg       Date:  2014-05-20       Impact factor: 3.445

3.  Does Intraoperative Frozen Section and Revision of Margins Lead to Improved Survival in Patients Undergoing Resection of Perihilar Cholangiocarcinoma? A Systematic Review and Meta-analysis.

Authors:  Tori Lenet; Richard W D Gilbert; Rory Smoot; Ching-Wei D Tzeng; Flavio G Rocha; Lavanya Yohanathan; Sean P Cleary; Guillaume Martel; Kimberly A Bertens
Journal:  Ann Surg Oncol       Date:  2022-06-25       Impact factor: 4.339

Review 4.  Multimodal treatment strategies for advanced hilar cholangiocarcinoma.

Authors:  Matthew J Weiss; David Cosgrove; Joseph M Herman; Neda Rastegar; Ihab Kamel; Timothy M Pawlik
Journal:  Langenbecks Arch Surg       Date:  2014-06-25       Impact factor: 3.445

Review 5.  Hilar cholangiocarcinoma: diagnosis, treatment options, and management.

Authors:  Kevin C Soares; Ihab Kamel; David P Cosgrove; Joseph M Herman; Timothy M Pawlik
Journal:  Hepatobiliary Surg Nutr       Date:  2014-02       Impact factor: 7.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.